Interestingly, this group found that miR30a/c-5p directly targets DNMT1 3′UTR, inhibiting its expression and directing a feedback loop that uncovers additional mechanisms in ovarian cancer drug resistance. This evidence concerns the gene DNMT1 and ovarian cancer.